WAVE Life Sciences Ltd. (NasdaqGM:WVE) has filed a Shelf Registration in the amount of $500 million. WAVE Life Sciences states, "We intend to use any net proceeds from the sale of securities under this prospectus for our operations and for other general corporate purposes, including, but not limited to, repayment or refinancing of existing indebtedness or other corporate borrowings, working capital, intellectual property protection and enforcement, capital expenditures, investments, acquisitions or collaborations, repurchases and redemption of our securities, research and development and product development."